Tejas Savant
Stock Analyst at Morgan Stanley
(3.49)
Main Sectors:
39 Stocks
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
TEM Tempus AI | Maintains: Overweight | 65 68 | 91.66 | -25.81% | 4 | Aug 12, 2025 | |
TXG 10x Genomics | Maintains: Overweight | 18 17 | 12.75 | 33.33% | 15 | Aug 12, 2025 | |
ILMN Illumina | Maintains: Equal-Weight | 100 105 | 102.12 | 2.82% | 9 | Aug 4, 2025 | |
AVTR Avantor | Maintains: Equal-Weight | 15 12 | 14.29 | -16.03% | 20 | Aug 4, 2025 | |
HOLX Hologic | Maintains: Equal-Weight | 65 69 | 68.22 | 1.14% | 10 | Jul 31, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 10 8 | 9.1 | -12.09% | 14 | Jul 30, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 9 7 | 3.97 | 76.32% | 9 | May 28, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 8 7 | 9.68 | -27.69% | 2 | May 5, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 7 9 | 14.38 | -37.41% | 12 | May 5, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 7 5 | 3.09 | 61.81% | 13 | Mar 25, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 16 20 | 65.55 | -69.49% | 2 | Mar 18, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 176 185 | 167.35 | 10.55% | 13 | Mar 5, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 245 250 | 206.62 | 21% | 11 | Feb 11, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 647 678 | 543.55 | 24.74% | 14 | Jan 31, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Equal-Weight | 24 23 | 26 | -11.54% | 1 | Dec 3, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 26 28 | 36 | -22.22% | 12 | Nov 18, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 32 21 | 8.06 | 160.55% | 2 | Nov 18, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 4 2 | 1.49 | 34.23% | 11 | Aug 12, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 4 3 | n/a | n/a | 10 | Aug 6, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 80 40 | 16.14 | 147.83% | 2 | May 15, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 26 26 | n/a | n/a | 12 | Mar 26, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 14 8 | n/a | n/a | 11 | Oct 24, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 52 55 | n/a | n/a | 11 | Aug 30, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Equal-Weight | 1 | n/a | n/a | 1 | Aug 18, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Equal-Weight | 6 6 | 0.88 | 581.82% | 3 | Aug 3, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 11 10 | 4.4 | 127.27% | 8 | May 10, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Equal-Weight | 3 | 3.79 | -27.44% | 6 | Mar 7, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 11 5 | 7.34 | -31.88% | 12 | Feb 27, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 11 10 | 2.28 | 338.6% | 10 | Feb 21, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 80 73 | 62.84 | 16.17% | 9 | Feb 21, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 5 2 | n/a | n/a | 5 | Jan 5, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 10 8 | n/a | n/a | 4 | Aug 11, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underweight | 10 5 | n/a | n/a | 8 | Aug 10, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 350 250 | 177.39 | 40.93% | 1 | Aug 4, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 140 100 | 7.75 | 1190.32% | 5 | May 12, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 17 19 | n/a | n/a | 3 | May 6, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 18 17 | n/a | n/a | 8 | May 4, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 21 20 | n/a | n/a | 2 | Mar 15, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 35 65 | n/a | n/a | 1 | Feb 22, 2021 |